Meet Kibion at JFBM
Kibion will exhibit at JFBM October 5 – 7, 2022 in St Etienne, France. Please come and visit us on booth 38. We will be happy to demonstrate our product with you.
Kibion will exhibit at JFBM October 5 – 7, 2022 in St Etienne, France. Please come and visit us on booth 38. We will be happy to demonstrate our product with you.
At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.
In 2011 Orexo acquired the German company Wagner Analysen Technik GmbH, a leading manufacturer of IRIS™ instruments for analyzing diagnostic breath tests. Integrating these two businesses transformed Kibion into a complete solutions provider of diagnostic breath tests and instrumentation, and a leading player in Helicobacter pylori testing.
The 30th of April 2015, Kibion was acquired by a team of Swedish investors and business developers. Through this investment Kibion will strengthen its operations and continue to grow.
The 30th of September 2016, Kibion was acquired by the French company Laboratory Mayoly Spindler. This acquisition will strengthen both companies’ global and generate outstanding synergies. Kibion is now successfully integrated into the Mayoly Group.
In 2011 Orexo acquired the German company Wagner Analysen Technik GmbH, a leading manufacturer of IRIS™ instruments for analyzing diagnostic breath tests. Integrating these two businesses transformed Kibion into a complete solutions provider of diagnostic breath tests and instrumentation, and a leading player in Helicobacter pylori testing.
The 30th of April 2015, Kibion was acquired by a team of Swedish investors and business developers. Through this investment Kibion will strengthen its operations and continue to grow.
H. pylori infection is the major cause of ulcer disease and gastritis worldwide, which is often present as gnawing or burning epigastric pain. Designated as a carcinogen by the World Health Organization, H. pylori infection is the strongest known risk factor for non-cardia gastric adenocarcinoma. Infected people have a 2–6-fold increased risk of developing gastric cancer and mucosal associated-lymphoid-type (MALT) lymphoma compared with their uninfected counterparts.
UBT is the most investigated and best recommended non-invasive test in the context of a ‘test-and-treat strategy.
The 13C-UBT is widely employed for the diagnosis of H. pylori infection as well as to verify successful eradication after treatment.
Kibion, whose name originates from the old Nordic “Kibi” meaning smart and alert, offers innovative yet trustworthy solutions. The company currently supplies test systems and high-quality instruments to diagnose Helicobacter pylori infections. In addition, it continuously evaluates new business opportunities within its field of operations.
Kibion provides customers with high quality products and services.
Kibion GmbH in Bremen, Germany, is dedicated to supporting all customers.
We will all do our best to answer your queries.
SCIENTIFIC
INSTUCTIONS
Download scientific publications in pdf format by clicking below:
FAQ
Helicobacter Pylori
History
e-IFU
INSTUCTIONS
Download instructions for use in pdf format by clicking below: